https://stock.noler.com/us/stock/cytof https://stock.noler.com/us/stock/cytof/13f-holdings https://stock.noler.com/us/stock/cytof/accounting-profit https://stock.noler.com/us/stock/cytof/accruals-classified-as-current https://stock.noler.com/us/stock/cytof/activist-13d-13g https://stock.noler.com/us/stock/cytof/actuarial-assumption-of-discount-rates https://stock.noler.com/us/stock/cytof/actuarial-assumption-of-expected-rates-of-pension-increases https://stock.noler.com/us/stock/cytof/actuarial-assumption-of-expected-rates-of-salary-increases https://stock.noler.com/us/stock/cytof/actuarial-gains-losses-arising-from-changes-in-demographic-assumptions-net-defined-benefit-liability-asset https://stock.noler.com/us/stock/cytof/actuarial-gains-losses-arising-from-changes-in-financial-assumptions-net-defined-benefit-liability-asset https://stock.noler.com/us/stock/cytof/actuarial-gains-losses-arising-from-experience-adjustments-net-defined-benefit-liability-asset https://stock.noler.com/us/stock/cytof/additions-to-rightofuse-assets https://stock.noler.com/us/stock/cytof/adjusted-weighted-average-shares https://stock.noler.com/us/stock/cytof/adjustments-for-decrease-increase-in-inventories https://stock.noler.com/us/stock/cytof/adjustments-for-decrease-increase-in-other-operating-receivables https://stock.noler.com/us/stock/cytof/adjustments-for-decrease-increase-in-prepaid-expenses https://stock.noler.com/us/stock/cytof/adjustments-for-decrease-increase-in-trade-and-other-receivables https://stock.noler.com/us/stock/cytof/adjustments-for-depreciation-expense https://stock.noler.com/us/stock/cytof/adjustments-for-fair-value-gains-losses https://stock.noler.com/us/stock/cytof/adjustments-for-finance-costs https://stock.noler.com/us/stock/cytof/adjustments-for-gains-losses-on-change-in-fair-value-of-derivatives https://stock.noler.com/us/stock/cytof/adjustments-for-impairment-loss-reversal-of-impairment-loss-recognised-in-profit-or-loss https://stock.noler.com/us/stock/cytof/adjustments-for-income-tax-expense https://stock.noler.com/us/stock/cytof/adjustments-for-increase-decrease-in-employee-benefit-liabilities https://stock.noler.com/us/stock/cytof/adjustments-for-increase-decrease-in-trade-account-payable https://stock.noler.com/us/stock/cytof/adjustments-for-increase-decrease-in-trade-and-other-payables https://stock.noler.com/us/stock/cytof/adjustments-for-interest-expense https://stock.noler.com/us/stock/cytof/adjustments-for-interest-income https://stock.noler.com/us/stock/cytof/adjustments-for-reconcile-profit-loss https://stock.noler.com/us/stock/cytof/adjustments-for-share-based-payments https://stock.noler.com/us/stock/cytof/adjustments-for-unrealised-foreign-exchange-losses-gains https://stock.noler.com/us/stock/cytof/administrative-expense https://stock.noler.com/us/stock/cytof/amended-reports-10-k https://stock.noler.com/us/stock/cytof/amortisation-expense https://stock.noler.com/us/stock/cytof/amortisation-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/cytof/amounts-payable-related-party-transactions https://stock.noler.com/us/stock/cytof/analyst-ratings-buy https://stock.noler.com/us/stock/cytof/analyst-ratings-hold https://stock.noler.com/us/stock/cytof/analyst-ratings-no-rating https://stock.noler.com/us/stock/cytof/analyst-ratings-sell https://stock.noler.com/us/stock/cytof/applicable-tax-rate https://stock.noler.com/us/stock/cytof/asset-impairment-charges https://stock.noler.com/us/stock/cytof/assets-liabilities-of-benefit-plan https://stock.noler.com/us/stock/cytof/auditor https://stock.noler.com/us/stock/cytof/auditors-remuneration https://stock.noler.com/us/stock/cytof/average-effective-tax-rate https://stock.noler.com/us/stock/cytof/average-exercise-price-of-share-options-exercisable-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/average-exercise-price-of-share-options-exercised-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/average-exercise-price-of-share-options-expired-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/average-exercise-price-of-share-options-expired-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/cytof/average-exercise-price-of-share-options-forfeited-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/average-exercise-price-of-share-options-granted-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/average-exercise-price-of-share-options-granted-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/cytof/average-exercise-price-of-share-options-outstanding-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/balances-with-banks https://stock.noler.com/us/stock/cytof/bank-overdrafts-classified-as-cash-equivalents https://stock.noler.com/us/stock/cytof/basic-and-diluted-earnings-loss-per-share https://stock.noler.com/us/stock/cytof/basic-earnings-loss-per-instrument-from-participating-equity-instruments-other-than-ordinary-shares https://stock.noler.com/us/stock/cytof/basic-earnings-loss-per-share https://stock.noler.com/us/stock/cytof/basic-earnings-loss-per-share-from https://stock.noler.com/us/stock/cytof/basic-earnings-loss-per-share-from-discontinued-operations https://stock.noler.com/us/stock/cytof/benefits-paid-or-payable https://stock.noler.com/us/stock/cytof/borrowings https://stock.noler.com/us/stock/cytof/borrowings-interest-rate https://stock.noler.com/us/stock/cytof/business https://stock.noler.com/us/stock/cytof/buybacks https://stock.noler.com/us/stock/cytof/cash https://stock.noler.com/us/stock/cytof/cash-and-cash-equivalents https://stock.noler.com/us/stock/cytof/cash-and-cash-equivalents-percentage-contributed-to-fair-value-of-plan-assets https://stock.noler.com/us/stock/cytof/cash-flow-breakdown https://stock.noler.com/us/stock/cytof/cash-flows-from-losing-control-of-subsidiaries-or-other-businesses-classified-as-investing-activities https://stock.noler.com/us/stock/cytof/cash-flows-from-used-in-financing-activities https://stock.noler.com/us/stock/cytof/cash-flows-from-used-in-financing-activities-discontinued-operations https://stock.noler.com/us/stock/cytof/cash-flows-from-used-in-investing-activities https://stock.noler.com/us/stock/cytof/cash-flows-from-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/cytof/cash-flows-from-used-in-operating-activities https://stock.noler.com/us/stock/cytof/cash-flows-from-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/cytof/cash-flows-from-used-in-operations https://stock.noler.com/us/stock/cytof/cash-flows-used-in-obtaining-control-of-subsidiaries-or-other-businesses-classified-as-investing-activities https://stock.noler.com/us/stock/cytof/cash-on-hand https://stock.noler.com/us/stock/cytof/cash-transferred https://stock.noler.com/us/stock/cytof/clinical-trials https://stock.noler.com/us/stock/cytof/company-guidance https://stock.noler.com/us/stock/cytof/company-profile https://stock.noler.com/us/stock/cytof/comprehensive-income https://stock.noler.com/us/stock/cytof/comprehensive-income-attributable-to-owners-of-parent https://stock.noler.com/us/stock/cytof/congressional-trades-stocks-including-adrs https://stock.noler.com/us/stock/cytof/contributions-to-plan-by-employer-net-defined-benefit-liability-asset https://stock.noler.com/us/stock/cytof/contributions-to-plan-by-plan-participants-net-defined-benefit-liability-asset https://stock.noler.com/us/stock/cytof/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/cytof/convertible-securities-retired https://stock.noler.com/us/stock/cytof/cost-of-sales https://stock.noler.com/us/stock/cytof/cover-page-shares-outstanding https://stock.noler.com/us/stock/cytof/current-accrued-expenses-and-other-current-liabilities https://stock.noler.com/us/stock/cytof/current-accrued-income-including-current-contract-assets https://stock.noler.com/us/stock/cytof/current-advances-to-suppliers https://stock.noler.com/us/stock/cytof/current-assets https://stock.noler.com/us/stock/cytof/current-borrowings-and-current-portion-of-noncurrent-borrowings https://stock.noler.com/us/stock/cytof/current-derivative-financial-assets https://stock.noler.com/us/stock/cytof/current-derivative-financial-liabilities https://stock.noler.com/us/stock/cytof/current-financial-assets-at-amortised-cost https://stock.noler.com/us/stock/cytof/current-financial-liabilities-at-amortised-cost https://stock.noler.com/us/stock/cytof/current-lease-liabilities https://stock.noler.com/us/stock/cytof/current-liabilities https://stock.noler.com/us/stock/cytof/current-portion-of-longterm-borrowings https://stock.noler.com/us/stock/cytof/current-prepaid-expenses https://stock.noler.com/us/stock/cytof/current-prepayments https://stock.noler.com/us/stock/cytof/current-prepayments-and-other-current-assets https://stock.noler.com/us/stock/cytof/current-ratio https://stock.noler.com/us/stock/cytof/current-receivables-from-taxes-other-than-income-tax https://stock.noler.com/us/stock/cytof/current-service-cost-net-defined-benefit-liability-asset https://stock.noler.com/us/stock/cytof/current-tax-assets https://stock.noler.com/us/stock/cytof/current-tax-expense-income https://stock.noler.com/us/stock/cytof/current-value-added-tax-receivables https://stock.noler.com/us/stock/cytof/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/cytof/debt-convertible-conversion-price https://stock.noler.com/us/stock/cytof/debt-equity-ratio https://stock.noler.com/us/stock/cytof/deductible-temporary-differences-for-which-no-deferred-tax-asset-is-recognised https://stock.noler.com/us/stock/cytof/deferred-tax-assets https://stock.noler.com/us/stock/cytof/deferred-tax-expense-income https://stock.noler.com/us/stock/cytof/deferred-tax-expense-income-recognised-in-profit-or-loss https://stock.noler.com/us/stock/cytof/deferred-tax-liabilities https://stock.noler.com/us/stock/cytof/deferred-tax-liability-asset https://stock.noler.com/us/stock/cytof/deferred-tax-relating-to-items-charged-or-credited-directly-to-equity https://stock.noler.com/us/stock/cytof/defined-benefit-obligation-at-present-value https://stock.noler.com/us/stock/cytof/depreciation-expense https://stock.noler.com/us/stock/cytof/derivative-financial-assets https://stock.noler.com/us/stock/cytof/derivatives-percentage-contributed-to-fair-value-of-plan-assets https://stock.noler.com/us/stock/cytof/description-of-expected-volatility-share-options-granted https://stock.noler.com/us/stock/cytof/description-of-risk-free-interest-rate-share-options-granted https://stock.noler.com/us/stock/cytof/diluted-earnings-loss-per-instrument-from-participating-equity-instruments-other-than-ordinary-shares https://stock.noler.com/us/stock/cytof/diluted-earnings-loss-per-share https://stock.noler.com/us/stock/cytof/diluted-earnings-loss-per-share-from https://stock.noler.com/us/stock/cytof/diluted-earnings-loss-per-share-from-discontinued-operations https://stock.noler.com/us/stock/cytof/dilutive-effect-of-convertible-instruments-on-number-of-ordinary-shares https://stock.noler.com/us/stock/cytof/dilutive-effect-of-share-options-on-number-of-ordinary-shares https://stock.noler.com/us/stock/cytof/disposals-property-plant-and-equipment https://stock.noler.com/us/stock/cytof/dividend https://stock.noler.com/us/stock/cytof/dividend-safety https://stock.noler.com/us/stock/cytof/dividends-paid-ordinary-shares-per-share https://stock.noler.com/us/stock/cytof/ebitda https://stock.noler.com/us/stock/cytof/ebitda-margin https://stock.noler.com/us/stock/cytof/effect-of-exchange-rate-changes-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/cytof/employee-benefits-expense https://stock.noler.com/us/stock/cytof/employee-count https://stock.noler.com/us/stock/cytof/equity https://stock.noler.com/us/stock/cytof/equity-and-liabilities https://stock.noler.com/us/stock/cytof/equity-attributable-to-owners-of-parent https://stock.noler.com/us/stock/cytof/estimate-of-contributions-expected-to-be-paid-to-plan https://stock.noler.com/us/stock/cytof/executive-pay-pvp https://stock.noler.com/us/stock/cytof/executive-salary-officers https://stock.noler.com/us/stock/cytof/exercise-price-of-outstanding-share-options-2019 https://stock.noler.com/us/stock/cytof/exercise-price-share-options-granted-2019 https://stock.noler.com/us/stock/cytof/expected-cash-outflow-on-redemption-or-repurchase-of-puttable-financial-instruments https://stock.noler.com/us/stock/cytof/expected-dividend-as-percentage-share-options-granted https://stock.noler.com/us/stock/cytof/expense-breakdown https://stock.noler.com/us/stock/cytof/expense-from-equitysettled-share-based-payment-transactions-in-which-goods-or-services-received-did-not-qualify-for-recognition-as-assets https://stock.noler.com/us/stock/cytof/expense-from-share-based-payment-transactions-with-employees https://stock.noler.com/us/stock/cytof/expense-relating-to-shortterm-leases-for-which-recognition-exemption-has-been-used https://stock.noler.com/us/stock/cytof/expense-relating-to-variable-lease-payments-not-included-in-measurement-of-lease-liabilities https://stock.noler.com/us/stock/cytof/fair-value-of-acquired-receivables https://stock.noler.com/us/stock/cytof/fee-and-commission-expense https://stock.noler.com/us/stock/cytof/finance-costs https://stock.noler.com/us/stock/cytof/finance-income https://stock.noler.com/us/stock/cytof/finance-income-cost https://stock.noler.com/us/stock/cytof/financial-assets https://stock.noler.com/us/stock/cytof/financial-liabilities https://stock.noler.com/us/stock/cytof/finished-goods https://stock.noler.com/us/stock/cytof/form-144-stocks https://stock.noler.com/us/stock/cytof/form-n-port-stocks https://stock.noler.com/us/stock/cytof/gain-loss-on-changes-in-effect-of-limiting-reimbursement-rights-to-asset-ceiling https://stock.noler.com/us/stock/cytof/gain-loss-on-remeasurement-of-net-defined-benefit-liability-asset https://stock.noler.com/us/stock/cytof/gains-losses-on-change-in-fair-value-of-derivatives https://stock.noler.com/us/stock/cytof/gains-losses-on-exchange-differences-on-translation-recognised-in-profit-or-loss https://stock.noler.com/us/stock/cytof/gains-losses-on-net-monetary-position https://stock.noler.com/us/stock/cytof/gains-losses-recognised-in-profit-or-loss-fair-value-measurement-liabilities https://stock.noler.com/us/stock/cytof/gains-on-change-in-fair-value-of-derivatives https://stock.noler.com/us/stock/cytof/general-and-administrative-expense https://stock.noler.com/us/stock/cytof/general-and-administrative-expense-ifrs-full https://stock.noler.com/us/stock/cytof/graph https://stock.noler.com/us/stock/cytof/gross-lease-liabilities https://stock.noler.com/us/stock/cytof/gross-margin https://stock.noler.com/us/stock/cytof/gross-profit https://stock.noler.com/us/stock/cytof/impairment-loss https://stock.noler.com/us/stock/cytof/impairment-loss-recognised-in-profit-or-loss https://stock.noler.com/us/stock/cytof/impairment-loss-recognised-in-profit-or-loss-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/cytof/included-in-etf https://stock.noler.com/us/stock/cytof/income-tax-expense https://stock.noler.com/us/stock/cytof/income-tax-relating-to-components-of-other-comprehensive-income https://stock.noler.com/us/stock/cytof/income-tax-relating-to-exchange-differences-on-translation-of-other-comprehensive-income https://stock.noler.com/us/stock/cytof/income-tax-relating-to-remeasurements-of-defined-benefit-plans-of-other-comprehensive-income https://stock.noler.com/us/stock/cytof/increase-decrease-in-cash-and-cash-equivalents https://stock.noler.com/us/stock/cytof/increase-decrease-in-cash-and-cash-equivalents-before-effect-of-exchange-rate-changes https://stock.noler.com/us/stock/cytof/increase-decrease-in-cash-and-cash-equivalents-discontinued-operations https://stock.noler.com/us/stock/cytof/increase-decrease-in-net-defined-benefit-liability-asset-resulting-from-administration-costs-not-reflected-in-return-on-plan-assets https://stock.noler.com/us/stock/cytof/increase-decrease-in-net-defined-benefit-liability-asset-resulting-from-expense-income-in-profit-or-loss https://stock.noler.com/us/stock/cytof/increase-decrease-through-conversion-of-convertible-instruments https://stock.noler.com/us/stock/cytof/increase-decrease-through-exercise-of-options https://stock.noler.com/us/stock/cytof/increase-decrease-through-exercise-of-warrants-equity https://stock.noler.com/us/stock/cytof/increase-decrease-through-net-exchange-differences-property-plant-and-equipment https://stock.noler.com/us/stock/cytof/increase-decrease-through-net-exchange-differences-reimbursement-rights-at-fair-value https://stock.noler.com/us/stock/cytof/increase-decrease-through-other-contributions-by-owners https://stock.noler.com/us/stock/cytof/increase-decrease-through-share-based-payment-transactions https://stock.noler.com/us/stock/cytof/increase-decrease-through-transactions-with-owners https://stock.noler.com/us/stock/cytof/incremental-fair-value-granted-modified-share-based-payment-arrangements https://stock.noler.com/us/stock/cytof/insider-transactions https://stock.noler.com/us/stock/cytof/intangible-assets-acquired-by-way-of-government-grant https://stock.noler.com/us/stock/cytof/intangible-assets-acquired-by-way-of-government-grant-at-fair-value https://stock.noler.com/us/stock/cytof/intangible-assets-and-goodwill https://stock.noler.com/us/stock/cytof/intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/cytof/intangible-assets-under-development https://stock.noler.com/us/stock/cytof/interest-expense https://stock.noler.com/us/stock/cytof/interest-expense-defined-benefit-plans https://stock.noler.com/us/stock/cytof/interest-expense-income-net-defined-benefit-liability-asset https://stock.noler.com/us/stock/cytof/interest-expense-on-borrowings https://stock.noler.com/us/stock/cytof/interest-expense-on-lease-liabilities https://stock.noler.com/us/stock/cytof/interest-income-defined-benefit-plans https://stock.noler.com/us/stock/cytof/interest-income-on-impaired-financial-assets-accrued https://stock.noler.com/us/stock/cytof/interest-paid-classified-as-financing-activities https://stock.noler.com/us/stock/cytof/interest-receivable https://stock.noler.com/us/stock/cytof/interest-received-classified-as-investing-activities https://stock.noler.com/us/stock/cytof/inventories https://stock.noler.com/us/stock/cytof/inventories-total https://stock.noler.com/us/stock/cytof/inventory-writedown-2011 https://stock.noler.com/us/stock/cytof/investment-funds-percentage-contributed-to-fair-value-of-plan-assets https://stock.noler.com/us/stock/cytof/investment-income https://stock.noler.com/us/stock/cytof/investments-in-subsidiaries-joint-ventures-and-associates https://stock.noler.com/us/stock/cytof/iran-activity-notices-irannotice https://stock.noler.com/us/stock/cytof/issue-of-convertible-instruments https://stock.noler.com/us/stock/cytof/issue-of-equity https://stock.noler.com/us/stock/cytof/issued-capital https://stock.noler.com/us/stock/cytof/key-management-personnel-compensation https://stock.noler.com/us/stock/cytof/key-management-personnel-compensation-postemployment-benefits https://stock.noler.com/us/stock/cytof/key-management-personnel-compensation-share-based-payment https://stock.noler.com/us/stock/cytof/key-management-personnel-compensation-shortterm-employee-benefits https://stock.noler.com/us/stock/cytof/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/cytof/lease-and-sublease-payments-recognised-as-expense https://stock.noler.com/us/stock/cytof/lease-liabilities https://stock.noler.com/us/stock/cytof/liabilities https://stock.noler.com/us/stock/cytof/liability-asset-of-defined-benefit-plans https://stock.noler.com/us/stock/cytof/loans-and-receivables https://stock.noler.com/us/stock/cytof/longterm-borrowings https://stock.noler.com/us/stock/cytof/losses-on-disposals-of-property-plant-and-equipment https://stock.noler.com/us/stock/cytof/market-cap https://stock.noler.com/us/stock/cytof/material-contracts https://stock.noler.com/us/stock/cytof/maximum-exposure-to-credit-risk https://stock.noler.com/us/stock/cytof/minimum-finance-lease-payments-payable https://stock.noler.com/us/stock/cytof/net-deferred-tax-liabilities https://stock.noler.com/us/stock/cytof/net-foreign-exchange-gain https://stock.noler.com/us/stock/cytof/net-foreign-exchange-loss https://stock.noler.com/us/stock/cytof/net-income https://stock.noler.com/us/stock/cytof/net-margin https://stock.noler.com/us/stock/cytof/news https://stock.noler.com/us/stock/cytof/noncurrent-assets https://stock.noler.com/us/stock/cytof/noncurrent-assets-other-than-financial-instruments-deferred-tax-assets-postemployment-benefit-assets-and-rights-arising-under-insurance-contracts https://stock.noler.com/us/stock/cytof/noncurrent-derivative-financial-assets https://stock.noler.com/us/stock/cytof/noncurrent-derivative-financial-liabilities https://stock.noler.com/us/stock/cytof/noncurrent-financial-liabilities https://stock.noler.com/us/stock/cytof/noncurrent-lease-liabilities https://stock.noler.com/us/stock/cytof/noncurrent-lease-prepayments https://stock.noler.com/us/stock/cytof/noncurrent-liabilities https://stock.noler.com/us/stock/cytof/noncurrent-provisions-for-employee-benefits https://stock.noler.com/us/stock/cytof/nonderivative-financial-liabilities-undiscounted-cash-flows https://stock.noler.com/us/stock/cytof/notional-amount https://stock.noler.com/us/stock/cytof/number-of-instruments-granted-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/number-of-operating-segments https://stock.noler.com/us/stock/cytof/number-of-outstanding-share-options https://stock.noler.com/us/stock/cytof/number-of-share-options-exercisable-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/number-of-share-options-exercised-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/number-of-share-options-expired-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/number-of-share-options-forfeited-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/number-of-share-options-granted-in-share-based-payment-arrangement https://stock.noler.com/us/stock/cytof/number-of-shares-issued https://stock.noler.com/us/stock/cytof/number-of-shares-outstanding https://stock.noler.com/us/stock/cytof/oci-before-tax https://stock.noler.com/us/stock/cytof/oci-before-tax-gains-losses-on-remeasurements-of-defined-benefit-plans https://stock.noler.com/us/stock/cytof/oci-net-of-tax-change-in-value-of-time-value-of-options https://stock.noler.com/us/stock/cytof/oci-net-of-tax-exchange-differences-on-translation https://stock.noler.com/us/stock/cytof/oci-net-of-tax-gains-losses-from-investments-in-equity-instruments https://stock.noler.com/us/stock/cytof/oci-net-of-tax-gains-losses-on-remeasurements-of-defined-benefit-plans https://stock.noler.com/us/stock/cytof/oci-net-of-tax-gains-losses-on-revaluation https://stock.noler.com/us/stock/cytof/oci-net-of-tax-hedges-of-net-investments-in-foreign-operations https://stock.noler.com/us/stock/cytof/oci-that-will-be-reclassified-to-profit-or-loss-net-of-tax https://stock.noler.com/us/stock/cytof/oci-that-will-not-be-reclassified-to-profit-or-loss-before-tax https://stock.noler.com/us/stock/cytof/operating-expense https://stock.noler.com/us/stock/cytof/operating-margin https://stock.noler.com/us/stock/cytof/options-activity https://stock.noler.com/us/stock/cytof/other-cash-and-cash-equivalents https://stock.noler.com/us/stock/cytof/other-comprehensive-income https://stock.noler.com/us/stock/cytof/other-current-financial-liabilities https://stock.noler.com/us/stock/cytof/other-current-liabilities https://stock.noler.com/us/stock/cytof/other-current-payables https://stock.noler.com/us/stock/cytof/other-current-receivables https://stock.noler.com/us/stock/cytof/other-employee-expense https://stock.noler.com/us/stock/cytof/other-finance-cost https://stock.noler.com/us/stock/cytof/other-finance-income https://stock.noler.com/us/stock/cytof/other-finance-income-cost https://stock.noler.com/us/stock/cytof/other-income https://stock.noler.com/us/stock/cytof/other-noncurrent-assets https://stock.noler.com/us/stock/cytof/other-noncurrent-financial-assets https://stock.noler.com/us/stock/cytof/other-noncurrent-receivables https://stock.noler.com/us/stock/cytof/other-operating-income-expense https://stock.noler.com/us/stock/cytof/other-receivables https://stock.noler.com/us/stock/cytof/other-reserves https://stock.noler.com/us/stock/cytof/other-shortterm-employee-benefits https://stock.noler.com/us/stock/cytof/other-tax-effects-for-reconciliation-between-accounting-profit-and-tax-expense-income https://stock.noler.com/us/stock/cytof/outstanding-bonds https://stock.noler.com/us/stock/cytof/par-value-per-share https://stock.noler.com/us/stock/cytof/past-service-cost-net-defined-benefit-liability-asset https://stock.noler.com/us/stock/cytof/patents-active https://stock.noler.com/us/stock/cytof/payables-for-purchase-of-noncurrent-assets https://stock.noler.com/us/stock/cytof/payments-for-share-issue-costs https://stock.noler.com/us/stock/cytof/payments-of-lease-liabilities-classified-as-financing-activities https://stock.noler.com/us/stock/cytof/pb-ratio https://stock.noler.com/us/stock/cytof/pe-ratio https://stock.noler.com/us/stock/cytof/percentage-of-reasonably-possible-increase-in-actuarial-assumption https://stock.noler.com/us/stock/cytof/plan-assets-at-fair-value https://stock.noler.com/us/stock/cytof/portion-of-consideration-paid-received-consisting-of-cash-and-cash-equivalents https://stock.noler.com/us/stock/cytof/postemployment-benefit-expense-defined-benefit-plans https://stock.noler.com/us/stock/cytof/pre-tax-margin https://stock.noler.com/us/stock/cytof/preferred-shares https://stock.noler.com/us/stock/cytof/previous-etf-holding-it https://stock.noler.com/us/stock/cytof/price-fcf-ratio https://stock.noler.com/us/stock/cytof/proceeds-from-borrowings-classified-as-financing-activities https://stock.noler.com/us/stock/cytof/proceeds-from-exercise-of-options https://stock.noler.com/us/stock/cytof/proceeds-from-exercise-of-warrants https://stock.noler.com/us/stock/cytof/proceeds-from-issue-of-ordinary-shares https://stock.noler.com/us/stock/cytof/proceeds-from-issuing-shares https://stock.noler.com/us/stock/cytof/proceeds-from-sales-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/cytof/professional-fees-expense https://stock.noler.com/us/stock/cytof/profit-breakdown https://stock.noler.com/us/stock/cytof/profit-loss https://stock.noler.com/us/stock/cytof/profit-loss-attributable-to-ordinary-equity-holders-of-parent-entity-including-dilutive-effects https://stock.noler.com/us/stock/cytof/profit-loss-attributable-to-owners-of-parent https://stock.noler.com/us/stock/cytof/profit-loss-before-tax https://stock.noler.com/us/stock/cytof/profit-loss-from https://stock.noler.com/us/stock/cytof/profit-loss-from-attributable-to-ordinary-equity-holders-of-parent-entity https://stock.noler.com/us/stock/cytof/profit-loss-from-discontinued-operations https://stock.noler.com/us/stock/cytof/profit-loss-from-operating-activities https://stock.noler.com/us/stock/cytof/profit-loss-ifrs-full https://stock.noler.com/us/stock/cytof/property-plant-and-equipment https://stock.noler.com/us/stock/cytof/property-service-charge-expense https://stock.noler.com/us/stock/cytof/proportion-of-ownership-interest-in-subsidiary https://stock.noler.com/us/stock/cytof/ps-ratio https://stock.noler.com/us/stock/cytof/purchase-of-intangible-assets-classified-as-investing-activities https://stock.noler.com/us/stock/cytof/purchase-of-interests-in-investments-accounted-for-using-equity-method https://stock.noler.com/us/stock/cytof/purchase-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/cytof/purchases-of-goods-related-party-transactions https://stock.noler.com/us/stock/cytof/quick-ratio https://stock.noler.com/us/stock/cytof/receivables-from-sale-of-properties https://stock.noler.com/us/stock/cytof/reclassification-adjustments-on-exchange-differences-on-translation-net-of-tax https://stock.noler.com/us/stock/cytof/recognised-liabilities-defined-benefit-plan https://stock.noler.com/us/stock/cytof/repayments-of-borrowings-classified-as-financing-activities https://stock.noler.com/us/stock/cytof/repayments-of-current-borrowings https://stock.noler.com/us/stock/cytof/research-and-development https://stock.noler.com/us/stock/cytof/research-and-development-expense https://stock.noler.com/us/stock/cytof/reserve-of-change-in-value-of-foreign-currency-basis-spreads https://stock.noler.com/us/stock/cytof/reserve-of-exchange-differences-on-translation https://stock.noler.com/us/stock/cytof/reserve-of-share-based-payments https://stock.noler.com/us/stock/cytof/retained-earnings https://stock.noler.com/us/stock/cytof/return-on-plan-assets-excluding-interest-income-or-expense-net-of-tax-defined-benefit-plans https://stock.noler.com/us/stock/cytof/return-on-plan-assets-net-defined-benefit-liability-asset https://stock.noler.com/us/stock/cytof/return-on-tangible-equity https://stock.noler.com/us/stock/cytof/revenue https://stock.noler.com/us/stock/cytof/revenue-and-operating-income https://stock.noler.com/us/stock/cytof/revenue-breakdown https://stock.noler.com/us/stock/cytof/revenue-from-contracts-with-customers https://stock.noler.com/us/stock/cytof/revenue-from-government-grants https://stock.noler.com/us/stock/cytof/revenue-from-interest https://stock.noler.com/us/stock/cytof/revenue-from-royalties https://stock.noler.com/us/stock/cytof/revenue-from-sale-of-goods-related-party-transactions https://stock.noler.com/us/stock/cytof/revenue-of-combined-entity https://stock.noler.com/us/stock/cytof/rightofuse-assets https://stock.noler.com/us/stock/cytof/risk-exposure-associated-with-instruments-sharing-characteristic https://stock.noler.com/us/stock/cytof/roa https://stock.noler.com/us/stock/cytof/roe https://stock.noler.com/us/stock/cytof/roi https://stock.noler.com/us/stock/cytof/sales-and-marketing-expense https://stock.noler.com/us/stock/cytof/scorecard https://stock.noler.com/us/stock/cytof/sec-comment-letters-upload https://stock.noler.com/us/stock/cytof/sec-enforcement-actions https://stock.noler.com/us/stock/cytof/sec-filings-10-q https://stock.noler.com/us/stock/cytof/sec-filings-25-nse https://stock.noler.com/us/stock/cytof/sec-filings-8-k https://stock.noler.com/us/stock/cytof/sec-filings-px14a6g https://stock.noler.com/us/stock/cytof/sec-filings-s-4 https://stock.noler.com/us/stock/cytof/secondary-offerings https://stock.noler.com/us/stock/cytof/secured-bank-loans-received https://stock.noler.com/us/stock/cytof/selling-expense https://stock.noler.com/us/stock/cytof/services-expense https://stock.noler.com/us/stock/cytof/sga-expense https://stock.noler.com/us/stock/cytof/share-issue-related-cost https://stock.noler.com/us/stock/cytof/share-of-oci-of-associates-and-joint-ventures-accounted-for-using-equity-method-that-will-be-reclassified-to-profit-or-loss-net-of-tax https://stock.noler.com/us/stock/cytof/share-of-profit-loss-of-associates-and-joint-ventures-accounted-for-using-equity-method https://stock.noler.com/us/stock/cytof/share-premium https://stock.noler.com/us/stock/cytof/shareholders-equity https://stock.noler.com/us/stock/cytof/shares-issued https://stock.noler.com/us/stock/cytof/shares-outstanding https://stock.noler.com/us/stock/cytof/short-sale-volume https://stock.noler.com/us/stock/cytof/short-term-borrowings https://stock.noler.com/us/stock/cytof/shortterm-borrowings https://stock.noler.com/us/stock/cytof/shortterm-employee-benefits-accruals https://stock.noler.com/us/stock/cytof/shortterm-employee-benefits-expense https://stock.noler.com/us/stock/cytof/shortterm-investments-classified-as-cash-equivalents https://stock.noler.com/us/stock/cytof/social-security-contributions https://stock.noler.com/us/stock/cytof/stock-issued https://stock.noler.com/us/stock/cytof/stock-splits https://stock.noler.com/us/stock/cytof/subsidiaries https://stock.noler.com/us/stock/cytof/surplus-deficit-in-plan https://stock.noler.com/us/stock/cytof/tax-effect-of-expense-not-deductible-in-determining-taxable-profit-tax-loss https://stock.noler.com/us/stock/cytof/tax-effect-of-foreign-tax-rates https://stock.noler.com/us/stock/cytof/tax-effect-of-tax-losses https://stock.noler.com/us/stock/cytof/tax-expense-income-at-applicable-tax-rate https://stock.noler.com/us/stock/cytof/total-assets https://stock.noler.com/us/stock/cytof/total-liabilities https://stock.noler.com/us/stock/cytof/trade-and-other-current-payables https://stock.noler.com/us/stock/cytof/trade-and-other-current-receivables https://stock.noler.com/us/stock/cytof/trade-and-other-payables https://stock.noler.com/us/stock/cytof/trade-and-other-payables-to-trade-suppliers https://stock.noler.com/us/stock/cytof/trade-and-other-receivables-due-from-related-parties https://stock.noler.com/us/stock/cytof/trade-receivables https://stock.noler.com/us/stock/cytof/transaction-price-allocated-to-remaining-performance-obligations https://stock.noler.com/us/stock/cytof/travel-expense https://stock.noler.com/us/stock/cytof/undiscounted-operating-lease-payments-to-be-received https://stock.noler.com/us/stock/cytof/unused-tax-losses-for-which-no-deferred-tax-asset-recognised https://stock.noler.com/us/stock/cytof/value-added-tax-receivables https://stock.noler.com/us/stock/cytof/wages-and-salaries https://stock.noler.com/us/stock/cytof/weighted-average-lessees-incremental-borrowing-rate-applied-to-lease-liabilities-recognised-at-date-of-initial-application-of-ifrs-16 https://stock.noler.com/us/stock/cytof/weighted-average-remaining-contractual-life-of-outstanding-share-options https://stock.noler.com/us/stock/cytof/weighted-average-shares